AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

678.108

+1.8530.27%

Number of Gainers:8

Number of Losers:14

Number of Flat:21

PE:- -

High:681.356

Open:675.012

Low:672.626

Close:676.256

Volume:14.62M

Turnover:55.24M

Market Cap:95.18B

Float Cap:91.75B

Loading ...

Starpharma Holdings Independent Non-Executive Chairman Acquires 10% More Stock

Simply Wall St.

Flight Centre Stock And Other Founder Led Picks Worth A Closer Look

Simply Wall St.

3 Australian Dividend Powerhouses Offering 3% Yields In An Uncertain Rate Outlook

Simply Wall St.

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live

ASX Growth Stocks With High Insider Ownership

Simply Wall St.

Immuron CEO Lydeamore Presents at Emerging Growth Conference

Paradigm Biopharmaceuticals' Phase 3 Knee Osteoarthritis Trial to Continue Unchanged Following Safety Board Recommendation

MT Newswires Live

Clinuvel Plans Additional Preclinical Study of VLRX-L Controlled-Release Peptide Platform in Q1 2027

3 Founder Led Australian Stocks Worth A Closer Look Right Now

Simply Wall St.

OCC says crypto firms can pursue U.S. bank charters

Clinuvel Pharmaceuticals Identifies High-Potential Dose Formulations for Injectable Peptide Platform

MT Newswires Live

ASX Growth Stocks With High Insider Ownership And Up To 59% Revenue Growth

Simply Wall St.

Genesis Minerals And 2 Other ASX Stocks That Might Be Trading Below Estimated Value

Simply Wall St.

Global Drugmakers Invest Billions to Boost US Presence

Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy

MT Newswires Live

Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says

MT Newswires Live

Starpharma Holdings Secures AU$32 Million Through Fully Underwritten Entitlement Offer; Shares Fall 16%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/BK7508/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":678.1082,"timestamp":1787709443911,"preClose":676.2556,"halted":0,"volume":14619491,"delay":0,"changeRate":0.002739,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":1.8526,"latestTime":"08-26 11:57:26 AEST","open":675.01154,"high":681.3558,"low":672.6255,"amount":55235092,"amplitude":0.01291,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787724000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787702400000,1787724000000]],"turnoverRate":0.000573,"increases":9,"decrements":14,"flats":20,"marketCap":95177675074.5,"floatMarketCap":91748454100.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":681.3558,"amplitude":0.01291,"preClose":676.2556,"low":672.6255,"latestPrice":678.1082,"volume":14619491,"delay":0,"open":675.01154,"prevYearClose":644.3692,"prevWeekClose":653.313,"prevMonthClose":488.077,"prevQuarterClose":464.145,"fiveDayClose":646.662,"twentyDayClose":506.065,"sixtyDayClose":396.059,"secType":"PLATE","market":"AU","turnoverRate":0.000573,"marketCap":95177675074.5,"floatMarketCap":91748454100.375,"timestamp":1787709443911,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":8,"down":14,"flat":21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659127926","title":"Starpharma Holdings Independent Non-Executive Chairman Acquires 10% More Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659127926","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659127926?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:42","pubTimestamp":1786743751,"startTime":"0","endTime":"0","summary":"Potential Starpharma Holdings Limited ( ASX:SPL ) shareholders may wish to note that the Independent Non-Executive...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-independent-non-executive-chairman-acqui","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-independent-non-executive-chairman-acqui","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPL.AU","BK7508","BK7501","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124444","title":"Flight Centre Stock And Other Founder Led Picks Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124444","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124444?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:28","pubTimestamp":1786742934,"startTime":"0","endTime":"0","summary":"Switzerland has just posted its strongest quarterly GDP growth since 2021, with industry and services doing the heavy lifting. In a world where policy paths and inflation stories keep shifting, that kind of resilience puts extra attention on founders who stay deeply invested in their companies. This article highlights three founder led stocks from our screener that can help you focus on long term commitment over short term headlines.\nThe founder led stocks highlighted below are just a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-other-founder-led-picks-worth-a-clos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-other-founder-led-picks-worth-a-clos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7070","BK7043","BK7511","BK7046","BK7067","BK7508","MSB.AU","BK7501","FLT.AU","MQG.AU","MAQ.AU","BK7042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124711","title":"3 Australian Dividend Powerhouses Offering 3% Yields In An Uncertain Rate Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124711","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124711?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:33","pubTimestamp":1786728821,"startTime":"0","endTime":"0","summary":"With global inflation still exerting pressure and central banks keeping policy options open, reliable income has fresh appeal for investors who want clarity in a foggy rate outlook. High quality dividend powerhouses, often called Dividend Aristocrats, can offer consistent cash flows when bond yields and currencies move around. This article highlights three stocks from our Dividend Powerhouses screener that deliver 3%+ yields with covered, growing payouts.\nThe stocks covered below are just a...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-powerhouses-offering-3-yields-in-an-un","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-powerhouses-offering-3-yields-in-an-un","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","VAP.AU","QFN.AU","IIGF.AU","XJO.AU","CSL.AU","IOZ.AU","QRE.AU","OZF.AU","BBOZ.AU","OZR.AU","DACE.AU","GIVE.AU","BK4588","XAO.AU","VAS.AU","CPU.AU","IISV.AU","ARTY","BK7157","CBA.AU","VIG","AIPO","AGIX","E200.AU","VTHR","CHAT","BK4585","BK7135","BK7508","BK7067","EIGA.AU","QTOC","IMLC.AU","BK7503","BK7033","STW.AU","ZYAU.AU","SLF.AU","XKO.AU","GEAR.AU","BEAR.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659546140","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2659546140","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659546140?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:47","pubTimestamp":1786718874,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking modestly higher Friday morning, rising 0.32% to 3,016.75 on the S&P Asia 50 ADR Index, which is up 0.09% for the week so far.From North Asia, the gainers were led by mobile big data platform Aurora Mobile  and video display maker LG Display , which climbed 10% and 6.2% respectively. They were followed by semiconductor company Silicon Motion Technology  and diagnostic imaging centers company Concord Medical Services , which advanced 5.1% and 3.7% respectively.The decliners from North Asia were led by fintech firm LexinFintech , which fell 3.5%. It was followed by media company Phoenix New Media  and online game developer The9 , which were down 2% and 0.2% respectively.From South Asia, the gainers were led by lender HDFC Bank  and telecommunications operator Telekomunikasi Indonesia , which increased 0.8% and 0.7% respectively. They were followed by lender ICICI Bank , which was up 0.6%.The decliners from South","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4207","INFY","LU0918141705.HKD","LU2279701549.SGD","BK4548","LU1791710400.SGD","BK4141","BK4600","LU0630378429.USD","LU1282648689.USD","LU0348744763.USD","TLK","JG","BK7502","LU0528227936.USD","CCM.AU","HDB","BK4023","RDY.AU","SIMO","XITK","LX","BK4587","CAN.AU","SG9999004220.SGD","LU0918141887.USD","AFG","BK7508","CAN","LU0541501648.USD","NCTY","RDY","SIFY","BK4085","AIS","LU1267930656.SGD","SGXZ90724238.SGD","BK4532","LU0197229882.USD","LPL","LU1105468828.SGD","EDOG","LU0823039010.USD","LU0831103253.SGD","CCM","LU0181495838.USD","IBN","FENG","LU0791590937.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659235198","title":"ASX Growth Stocks With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2659235198","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659235198?lang=en_us&edition=fundamental","pubTime":"2026-08-14 03:08","pubTimestamp":1786648090,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a cautious start, with the S&P/ASX 200 futures indicating a slight dip, reflecting broader global economic concerns and fluctuating commodity prices. Amidst these conditions, growth companies with high insider ownership on the ASX are attracting attention for their potential resilience and alignment of interests between management and shareholders.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-wia/wia-gold-shares/news/asx-growth-stocks-with-high-insider-ownership-12","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-wia/wia-gold-shares/news/asx-growth-stocks-with-high-insider-ownership-12","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WZR.AU","AWJ.AU","BK7104","AV1.AU","LIN.AU","BK7016","BK7017","BK7023","BK7110","BK7036","BK7095","SKS.AU","CDA.AU","BK7093","AEM.AU","FRS.AU","TTT.AU","BK7084","PDI.AU","BK7501","WIA.AU","BK7096","BK7508","SPL.AU","AR1.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659538801","title":"Immuron CEO Lydeamore Presents at Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2659538801","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659538801?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:06","pubTimestamp":1786615589,"startTime":"0","endTime":"0","summary":"Immuron CEO Lydeamore presents at Emerging Growth ConferenceImmuron CEO Steven Lydeamore will present virtually at the Emerging Growth Conference on Aug. 19, 2026.Slot scheduled for 4:25 p.m. to 4:35 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1G4s0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMC.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659184174","title":"Paradigm Biopharmaceuticals' Phase 3 Knee Osteoarthritis Trial to Continue Unchanged Following Safety Board Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659184174","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659184174?lang=en_us&edition=fundamental","pubTime":"2026-08-13 09:25","pubTimestamp":1786584355,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  said an independent Data Safety Monitoring Board recommended that the company's phase 3 clinical trial of a knee osteoarthritis treatment continue without modification, according to a Thursday filing with the Australian bourse.The trial is evaluating injectable pentosan polysulfate sodium in participants with knee osteoarthritis, with the change in pain intensity at day 112 set as the primary endpoint.The safety board issued the recommendation after completing a review of about 80% of the participants who have completed dosing, the company said.The trial's interim analysis remains on track for September.Paradigm Biopharmaceuticals shares gained 1% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658976515","title":"Clinuvel Plans Additional Preclinical Study of VLRX-L Controlled-Release Peptide Platform in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2658976515","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658976515?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:13","pubTimestamp":1786529595,"startTime":"0","endTime":"0","summary":"Clinuvel plans additional preclinical study of VLRX-L controlled-release peptide platform in Q1 2027Clinuvel updated on VLRX-L, a controlled-release liquid injectable peptide platform, following precl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLX8KKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CUV.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658731819","title":"3 Founder Led Australian Stocks Worth A Closer Look Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2658731819","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658731819?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:41","pubTimestamp":1786516885,"startTime":"0","endTime":"0","summary":"With oil prices feeding into higher bond yields across major markets, investors are being reminded how quickly macro shocks can ripple through portfolios. In choppier conditions, founder led companies can look appealing because leaders often hold significant stakes and stay focused on long term value creation rather than quarterly targets. This article highlights three stocks from the Founder Led Companies screener that fit that mindset and may interest long term investors.\nThe stocks covered...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-worth-a-closer-look-right-no","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-worth-a-closer-look-right-no","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IISV.AU","XJO.AU","SLF.AU","STW.AU","QRE.AU","BK7508","MAQ.AU","BK7501","GEAR.AU","BEAR.AU","BK7070","DACE.AU","EIGA.AU","BK7046","IIGF.AU","BK7043","IOZ.AU","VAS.AU","BK7042","FLT.AU","OZR.AU","E200.AU","BK7067","ZYAU.AU","BK7511","MQG.AU","XKO.AU","VAP.AU","QFN.AU","BBOZ.AU","IMLC.AU","GIVE.AU","XAO.AU","OZF.AU","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658923031","title":"OCC says crypto firms can pursue U.S. bank charters","url":"https://stock-news.laohu8.com/highlight/detail?id=2658923031","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658923031?lang=en_us&edition=fundamental","pubTime":"2026-08-12 12:46","pubTimestamp":1786509962,"startTime":"0","endTime":"0","summary":"The Office of the Comptroller of the Currency  said on Aug. 11 that digital asset companies conducting legally permissible activities should have a route into the U.S. national banking system, as Comptroller Jonathan V. Gould renewed the agency’s push to revive new bank formation.OCC received 40 de novo applications during 18 months, including applications for national trust banks.Digital asset firms conducting legally permissible activities should have bank pathways, Comptroller Jonathan Gould said.OCC currently lists 13 pending digital asset licensing applications, including Payward, Revolut and World Liberty.OCC denied Wise National Trust’s charter application July 21, showing approvals remain subject to review.OCC crypto bank charter pipeline has 13 pending applications. The FDIC’s new process applies to federal deposit insurance applications received after Aug. 15. Phase one begins when an application arrives and a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/occ-says-crypto-firms-can-pursue-u-s-bank-charters/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/occ-says-crypto-firms-can-pursue-u-s-bank-charters/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["APT.USD.CC","BK4020","OCC","BITQ","APT.USD.HKCC","LFGY","CRPT","STCE","DAPP","BKCH","OCC.AU","TEKX","BITW","NCIQ","GDLC","BK7067","DIME","BK7508","TON.USD.CC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658245944","title":"Clinuvel Pharmaceuticals Identifies High-Potential Dose Formulations for Injectable Peptide Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2658245944","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658245944?lang=en_us&edition=fundamental","pubTime":"2026-08-12 08:34","pubTimestamp":1786494881,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) said it identified flexible liquid dose formulations that have shown the most potential for further development as part of its VLRX-L injectable peptide formulation ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460839","title":"ASX Growth Stocks With High Insider Ownership And Up To 59% Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460839","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:08","pubTimestamp":1786475289,"startTime":"0","endTime":"0","summary":"As the S&P/ASX 200 index faces a potential slide amid rising oil prices and geopolitical tensions, investors are closely watching how these factors might influence market dynamics. In such an environment, growth companies with high insider ownership can be particularly appealing, as they often demonstrate strong alignment between management and shareholders, potentially leading to more resilient performance during uncertain times.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-eol/energy-one-shares/news/asx-growth-stocks-with-high-insider-ownership-and-up-to-59-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-eol/energy-one-shares/news/asx-growth-stocks-with-high-insider-ownership-and-up-to-59-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPL.AU","BK7036","BK7095","TTT.AU","FRS.AU","BK7023","LYL.AU","SMI.AU","AWJ.AU","AV1.AU","BK7016","EOL.AU","BK7110","PDI.AU","BK7055","SKS.AU","BK7104","BK7017","BK7501","BK7508","BK7096","AEM.AU","WZR.AU","BK7093","AR1.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658461769","title":"Genesis Minerals And 2 Other ASX Stocks That Might Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2658461769","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658461769?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:04","pubTimestamp":1786475095,"startTime":"0","endTime":"0","summary":"As the S&P/ASX 200 index is poised to open lower amid rising oil prices and geopolitical tensions, investors are closely watching market dynamics that could impact valuations. In such a climate, identifying undervalued stocks like Genesis Minerals can be crucial for those looking to capitalize on potential opportunities in the Australian market.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/genesis-minerals-and-2-other-asx-stocks-that-might-be-tradin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/genesis-minerals-and-2-other-asx-stocks-that-might-be-tradin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","OZF.AU","BK7501","BK7508","BK7051","XRO.AU","BK4585","XAO.AU","ZYAU.AU","ABV.AU","VAP.AU","SPHQ","BK7067","BK4109","BK7016","MSB.AU","IIGF.AU","BBOZ.AU","BK7503","E200.AU","LOV.AU","BEAR.AU","VAS.AU","XJO.AU","GMD.AU","ARX.AU","DACE.AU","BGL.AU","BK7015","QFN.AU","NWH.AU","BK7055","BK7128","OZR.AU","QRE.AU","EIGA.AU","STW.AU","XKO.AU","BK4588","BK7104","GIVE.AU","LYL.AU","SLF.AU","IMLC.AU","FDV.AU","IISV.AU","MTX","IOZ.AU","BK7002","SLC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911015","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:57","pubTimestamp":1786463857,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 11 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44815K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU0320765489.SGD","LU1196500208.SGD","LU0124676726.USD","LU1066051811.HKD","IE00BFSS7M15.SGD","LU1035775433.USD","LU1670711040.USD","LU2264538146.SGD","LU2125909247.SGD","LU0889565916.HKD","LU0096364046.USD","LU1989772923.USD","SG9999015945.SGD","LU0130517989.USD","LU0130102774.USD","SG9999014575.USD","LU0158827781.USD","LU0640476718.USD","LU0726765562.USD","LU2471134879.HKD","LU2237443382.USD","LU0234572021.USD","BK4550","IE00B42XCP33.USD","SG9999001440.SGD","LU0203201768.USD","VHT","LU1093756325.SGD","LU0672654240.SGD","LU1989771016.USD","XLV","LU1116320901.HKD","IE00BDGV0183.EUR","ELIS","LU2111349929.HKD","BK7067","LU2357305700.SGD","IE0009355771.USD","TBXU","LU1934455194.USD","LU2462591350.SGD","SG9999011175.SGD","LU2361044865.SGD","IE00BBT3K403.USD","LU0162691827.USD","LU1814569148.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU0859254822.USD","CANC","LU0395794307.EUR","LU1548497426.USD","PPH","LU1201861249.SGD","LU0203347892.USD","LU2456880835.USD","LU0345769128.USD","LU0306807586.USD","MHIP","NVO","BK4592","PAWZ","LU1868836757.USD","LU2028103732.USD","IE000MB6IJN5.SGD","LU1670628061.USD","LU0661504455.SGD","LU0456855351.SGD","IE000BZT7R73.USD","IE0002141913.USD","LU1221951129.SGD","LU0098860793.USD","LU0057025933.USD","IE00B19Z9P08.USD","LU0426417589.USD","LU0310799852.SGD","LU0787776722.HKD","LU2237443978.SGD","LU0321505868.SGD","BK4581","IE0005OL40V9.USD","BK4534","LLYX","LU2491050071.SGD","IE00BN8TJ469.HKD","LU1935042991.SGD","LU0234570918.USD","LU0472753341.HKD","IE00B3PB1722.GBP","LU0198837287.USD","LU1221951046.USD","LU1506573853.SGD","LU1868837136.USD","LU1778281490.HKD","BK4559","LU0029864427.USD","LU1674673691.USD","LU1496350171.SGD","LU1035773651.USD","IE00BSNM7G36.USD","LU2087621335.USD","LU0211327993.USD","LU0266013472.USD","LU2063271972.USD","LU1267930573.SGD","IE000SO60NU8.SGD","LU0053666078.USD","LU2433249047.HKD","BK7508","LU0545562505.USD","LU0466842654.USD","LU0203345920.USD","LU1232071149.USD","LU0203202063.USD","LU1670710661.SGD","IE00BFXG1179.USD","SNY","SGXZ57979304.SGD","LU2129689605.HKD","LU2347655156.SGD","LU0708994859.HKD","LU2403377893.USD","SG9999014567.USD","LU1868836591.USD","IE00B4R5TH58.HKD","SG9999003800.SGD","LU0006306889.USD","LU0058720904.USD","LU0353189763.USD","AMGN","IE00B4JS1V06.HKD","LU0985481810.HKD","LU2237443549.SGD","IXJ","LU0069063385.USD","IHE","LU2133065610.SGD","LU1267930813.SGD","HRTS","LU1093756168.USD","LU0820561909.HKD","LU0980610538.SGD","IE00B19Z3581.USD","LU0225283273.USD","LU2360032135.SGD","LU0861579265.USD","SG9999002232.USD","IE00BJJMRY28.SGD","LU0316494557.USD","LU2361044949.HKD","LU2471134796.USD","SG9999017495.SGD","LU0477156953.USD","LU0122379950.USD","LU1037948541.HKD","PBE","LU2168564065.EUR","LU2242652126.USD","LU0323591593.USD","ILDR","LU2106854487.HKD","GSKH","LU0210536198.USD","IE00BGHQF631.EUR","LU2430703178.SGD","LU1804176565.USD","LU0256863902.USD","LLYZ","IE0004445239.USD","LU0471298694.HKD","SGXZ51526630.SGD","LU0882574139.USD","SG9999015341.SGD","LU0225771236.USD","LU0786609619.USD","LU0882574055.USD","IE00B1BXHZ80.USD","LU2487616109.SGD","LU0471298777.SGD","SG9999002224.SGD","IE00BJLML261.HKD","03165","LU0094547139.USD","LU1066051498.USD","LU0417517546.SGD","LU0174119429.USD","LU1032466523.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","LU1732799900.SGD","LU1430594728.SGD","LU2211815571.USD","LU2746668974.SGD","LU0265550359.USD","LU2168564495.EUR","LU2750360641.GBP","IBBQ","LU1670710588.SGD","BK4599","LU2357627491.SGD","IE00BKVL7J92.USD","LU1894683264.USD","LU2168563687.JPY","PFE","LLII","LU2168564222.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU2237443622.USD","LU0354030511.USD","SG9999018865.SGD","LU1629891620.HKD","LU0943347566.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU1720051108.HKD","LU1066053197.SGD","LU1074936037.SGD","LU0211328371.USD","LU1291159041.SGD","LU1989772840.SGD","LU2023250504.SGD","LU2242646821.SGD","SG9999001176.SGD","LU1069347547.HKD","AZN","LU1061106388.HKD","LU1244550221.USD","TMED","BK4516","BIB","LU2756315318.SGD","LU0823434740.USD","LU0320765646.SGD","LU2023250843.SGD","SG9999015358.SGD","RHHBY","SG9999014906.USD","JNJ","SG9999018857.SGD","LU0345770308.USD","LU0683600562.USD","LU0097036916.USD","LU0354030438.USD","LU1670711123.USD","BK4139","IE00BN29S564.USD","IE00BVYPNW00.USD","LU1366192091.USD","LU2462157665.USD","LU0079474960.USD","BK4583","BK4504","MRK","IE00BFTCPJ56.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU0072461881.USD","AGNG","LU1043141396.HKD","LU1829250122.USD","LU2237443895.HKD","RXL","LU1699723380.USD","LU0965509010.AUD","LU1712237335.SGD","LU2471134952.CNY","LU2602419157.SGD","LU1069344957.HKD","LU0210528500.USD","PJP","LU0994945656.USD","SGXZ99366536.SGD","LU0225284248.USD","LU0267386448.USD","LU2125154778.USD","LU1057294990.SGD","IE00B894F039.SGD","LU0868494617.USD","LU0648001328.SGD","IE00BK4W5M84.HKD","IBB","GLAM","IE0034235303.USD","LU0823434583.USD","LU0985320562.USD","JDOC","LU0133085943.USD","NVOX","LU0061475181.USD","LU2756315664.SGD","SG9999015986.USD","LU1244550577.SGD","LU2129689514.USD","LU1032955483.USD","BMY","LU2461242641.AUD","OZEM","LU1127390331.HKD","LU1551013425.SGD","LU0820562030.AUD","IE00BK4W5L77.USD","LU2750360997.AUD","LU1623119135.USD","LU2087625088.SGD","IE0000B7K699.USD","LU1983299246.USD","LU0211331839.USD","BMED","LU1571399168.USD","NVOH","LU1868837300.USD","LU0385154629.USD","SG9999014542.SGD","SG9999001176.USD","LU0289739343.SGD","LU0689472784.USD","LU2125154935.USD","LU1868836914.USD","LU0158827948.USD","LU2596442595.SGD","LU1003077747.HKD","LU0128525929.USD","LU1914381329.SGD","LU0823416689.USD","LU1267930730.SGD","IE00B19Z9Z06.USD","LU0426412945.USD","LU2347655073.USD","LU0553294199.USD","LU2125909593.SGD","LU2896262040.SGD","LU1145028129.USD","LU0511384066.AUD","LU1720051017.SGD","LU2417539215.USD","LU1064131342.USD","LU0106261372.USD","LLY","LU1670627923.USD","LU0820561818.USD","IE00B1XK9C88.USD","LU0965509101.SGD","LU0432979614.USD","BK4578","LU2468319806.SGD","LU0795875169.SGD","LU2592432038.USD","LU2271345857.HKD","LU0109391861.USD","LU2213496289.HKD","LU0320765059.SGD","LU1267930490.SGD","IE0002270589.USD","LU2236285917.USD","ABBV","LU2023250330.USD","LU0109394709.USD","LU0889566641.SGD","FTXH","LU1228905540.USD","LU1674673428.USD","LU2168564149.EUR","MEDI","LU2505996681.GBP","LU0792757196.USD","IE00BKDWB100.SGD","LU2237438978.USD","MEDX","LU0689626769.HKD","LU1037948897.HKD","LU2089284900.SGD","BIIB","LU2265009873.SGD","LU1116320737.USD","SG9999014914.USD","LU2324357040.USD","LU1323610961.USD","BK4533","LU1732800096.USD","LU1228905037.USD","LU0912757837.SGD","LU0310800379.SGD","LU0738911758.USD","BBH","LU0070302665.USD","LU1979441026.SGD","LU1988902786.USD","IE00B19Z3B42.SGD","LU1066051225.USD","BK4585","LU0170899867.USD","LU2552382132.HKD","LU2361045086.USD","LU2552382215.SGD","SGXZ31699556.SGD","LU0320765992.SGD","LU2023251221.USD","IE0001KFT4U8.USD","LU1551013342.USD","04332","LU0289961442.SGD","LU2746668461.USD","LU0345769631.USD","NVS","SG9999015978.USD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","LU1934455863.HKD","SG9999015952.SGD","BK7501","LU1244550494.USD","LU2491050154.USD","LU0154236417.USD","LU2108987350.USD","GILD","AZNH","LU1923622614.USD","LU0070217475.USD","BK4568","IE000F7OJYX1.SGD","WDNA","IE00BJJMRZ35.SGD","LU1883839398.USD","BK7511","SG9999014880.SGD","GSK","LU0306806265.USD","ELIL","LU0208291251.USD","IE000WAW04H5.SGD","TRUH","BK4588","LU1974910355.USD","LU1894683348.USD","LU0321505439.SGD","LU0964807845.USD","CSL.AU","LU0795875086.SGD","LU0256863811.USD","LU2505996509.AUD","BK4566","SG9999014559.SGD","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1496350502.SGD","LU2471134523.USD","IE00B7SZLL34.SGD","IYH","LU2430703251.USD","LU0942090050.USD","LU2360106947.USD","IE00B775H168.HKD","SG9999013999.USD","CURE","LU0708995401.HKD","SG9999014898.SGD","LU0949170772.SGD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU0545039389.USD","LU1839511570.USD","LU1280957306.USD","IE0004445015.USD","LU1941712348.USD","LU2430703095.HKD","LU0237698245.USD","LU2237443465.HKD","LU0353189680.USD","LU1585245621.USD","LU1917777945.USD","IE00BKPKM429.USD","LU1941712264.USD","BK4007","LU0345770993.USD","IE00B7KXQ091.USD","SGXZ80539844.SGD","IE00B2B36J28.USD","LU1261432733.SGD","IE00BVYPNV92.GBP","GSK.UK","LU0868494708.USD","GDOC","LU1718418525.SGD","LU1059921491.USD","LU2552382058.USD","THNR","BK4532","LU1043141123.HKD","LU1121112475.USD","LU0238689110.USD","LU1934455277.USD","FHLC","LU2089283258.USD","LU1162221912.USD","IE00BFSS8Q28.SGD","SGXZ81514606.USD","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918639","title":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918639","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918639?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:13","pubTimestamp":1786443206,"startTime":"0","endTime":"0","summary":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","BK7503","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961945","title":"Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961945","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961945?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:50","pubTimestamp":1786423845,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) is nearing a \"genuine commercial inflection point\" as it transforms almost two decades of platform development into a recurring, high-margin revenue stream, Jarden sa","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963272","title":"Starpharma Holdings Secures AU$32 Million Through Fully Underwritten Entitlement Offer; Shares Fall 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963272","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658963272?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:22","pubTimestamp":1786411369,"startTime":"0","endTime":"0","summary":"Starpharma Holdings  secured AU$32 million before costs through its fully underwritten 1-for-7.5 renounceable entitlement offer, with around 99% shareholder participation, including AU$5.4 million raised through the oversubscription facility, according to a Tuesday Australian bourse filing.The company is expected to issue 56.1 million new shares on Tuesday, ranking equally with existing shares, per the filing.Eligible shareholders will receive their full applications under the oversubscription facility, while proceeds from the sale of ineligible foreign shareholders' rights will be distributed on Friday, the filing said.The proceeds will be used to fund the first-in-human and dose-escalation phases of a phase one study for a cancer treatment candidate, as well as advance additional oncology assets, the filing added.The company's shares fell around 16% in recent Tuesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7508","SPL.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":97,"code":"91000000","status":"200"}]}}